AJP - Regu AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 293: R2218-R2224, 2007. First published September 26, 2007; doi:10.1152/ajpregu.00295.2007
0363-6119/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Information
Right arrow All Versions of this Article:
293/6/R2218    most recent
00295.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mundy, A. L.
Right arrow Articles by Barton, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mundy, A. L.
Right arrow Articles by Barton, M.

INFLAMMATION AND CYTOKINES

Endothelin stimulates vascular hydroxyl radical formation: effect of obesity

Alexa L. Mundy,* Elvira Haas,* Indranil Bhattacharya,* Corinne C. Widmer, Martin Kretz, Karin Baumann, and Matthias Barton

Molecular Internal Medicine, Medical Policlinic, Department of Internal Medicine, University Hospital Zurich, Zürich, Switzerland

Submitted 27 April 2007 ; accepted in final form 19 September 2007

Reactive oxygen species (ROS) and endothelin-1 (ET-1) contribute to vascular pathophysiology in obesity. In this context, whether ET-1 modulates hydroxyl radical (bulletOH) formation and the function of ROS/bulletOH in obesity is not known. In the present study, formation and function of ROS, including bulletOH, were investigated in the aorta of lean and leptin-deficient obese ob/ob mice. Hydroxyl radical formation was detected ex vivo using terephthalic acid in intact aortic rings and the involvement of ROS in ET-1-mediated vasoreactivity was analyzed using the antioxidant EPC-K1, a combination of {alpha}-tocopherol and ascorbic acid. Generation of either bulletOH, bulletO2, and H2O2 was strongly inhibited by EPC-K1 (all P < 0.05). In obese mice, basal vascular bulletOH formation and ROS activity were reduced by 3-fold and 5-fold, respectively (P < 0.05 vs. lean). ET-1 markedly enhanced bulletOH formation in lean (6-fold, P < 0.05 vs. untreated) but not in obese mice. Obesity increased ET-1-induced contractions (P < 0.05 vs. lean), and ROS scavenging further enhanced the response (P < 0.05 vs. untreated). Exogenous ROS, including bulletOH caused stronger vasodilation in obese animals (P < 0.05 vs. lean), whereas endothelium-dependent relaxation was similar between lean and obese animals. In conclusion, we present a sensitive method allowing ex vivo measurement of vascular bulletOH generation and provide evidence that ET-1 regulates vascular bulletOH formation. The data indicate that in obesity, vascular formation of ROS, including bulletOH is lower, whereas the sensitivity to ROS is increased, suggesting a novel and important role of ROS, including bulletOH in the regulation of vascular tone in disease status associated with increased body weight.

oxidative stress; acetylcholine; vasoconstriction; murine; ob/ob; terephthalic acid; vitamin E; vitamin C



Address for reprint requests and other correspondence: M. Barton, Medical Policlinic, Dept. of Internal Medicine, Univ. Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland (e-mail: barton{at}usz.ch)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.